Purpose: To compare the capabilities of apparent diffusion coefficient (ADC) and normalized ADC using the pancreatic parenchyma as reference organ in the characterization of focal pancreatic lesions. Patients and methods: Thirty-six patients with focal pancreatic lesions (malignant, n = 18; benign tumors, n = 10; focal pancreatitis, n = 8) underwent diffusion-weighted MR imaging (DWI) at 1.5-Tesla using 3 b values (b = 0, 400, 800 s/mm 2 ). Lesion ADC and normalized lesion ADC (defined as the ratio of lesion ADC to apparently normal adjacent pancreas) were compared between lesion types using nonparametric tests. Results: Significant differences in ADC values were found between malignant (1.150 × 10 −3 mm 2 /s) and benign tumors (2.493 × 10 −3 mm 2 /s) (P = 0.004) and between benign tumors and mass-forming pancreatitis (1.160 × 10 −3 mm 2 /s) (P = 0.0005) but not between malignant tumors and mass-forming pancreatitis (P = 0.1092). Using normalized ADC,
significant differences were found between malignant tumors (0.933 × 10 −3 mm 2 /s), benign tumors (1.807 × 10 −3 mm 2 /s) and mass-forming pancreatitis (0.839 × 10 −3 mm 2 /s) (P < 0.0001). Conclusion: Our preliminary results suggest that normalizing ADC of focal pancreatic lesions with ADC of apparently normal adjacent pancreatic parenchyma provides higher degrees of characterization of focal pancreatic lesions than the conventional ADC does. © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
Diffusion-weighted magnetic resonance imaging (DWI) with quantitative measurement of apparent diffusion coefficient (ADC) values has a well-established role for the diagnosis of a variety of abdominal abnormalities [1] [2] [3] [4] [5] [6] [7] . Regarding pancreatic disease, several researchers have demonstrated that DWI with ADC measurement helps detect and further characterize focal pancreatic lesions [8] [9] [10] [11] as well as assess the severity of other pancreatic conditions [12, 13] . However, individual studies found conflicting results with respect to the capabilities of ADC measurement in differentiating between pancreatic cancers and mass-forming pancreatitis [14] [15] [16] , mostly because of an overlap in ADC values between these two entities [17] .
To limit the possible influence of technical parameters on the resulting ADC value, researchers have used a normalized ADC to improve characterization of pathologic conditions with DWI [18, 19] . However, this approach has not been evaluated yet for the characterization of focal pancreatic lesions.
Accordingly, we performed this study to compare the capabilities of apparent diffusion coefficient (ADC) with those of normalized ADC using the pancreatic parenchyma as reference in the characterization of focal pancreatic lesions.
Patients and methods

Patients
This retrospective study was performed according to the review board guidelines of our institution and informed Table 1 Demographic data of three groups of patients with focal pancreatic lesions.
Malignant tumors (n = 18)
Benign tumors (n = 10) Mass-forming pancreatitis (n = 8) consent was obtained from all patients. From January 2010 through January 2012, the MR imaging databases of two University Hospitals were retrospectively queried to identify all adult patients referred for MR imaging of the pancreas at 1.5-T. The electronic archiving systems of both institutions were then used to retrieve the subgroup of patients who had focal pancreatic lesions, as evidenced by the results of histopathological analysis either after surgery, endoscopic biopsy or percutaneous biopsy. The study population consisted of 36 patients (23 males and 13 females) with a mean age of 56 years ± 12.6 years (SD) (range: 21-80 years) who underwent DWI examination of the pancreas at 1.5-T.
Eighteen patients (50%) had malignant pancreatic tumors that consisted in 13 adenocarcinomas (including seven well-differentiated, three moderately and three poorly differentiated adenocarcinomas) and five non-secreting neuroendocrine tumors, 10 patients (28%) had benign tumors of the pancreas that consisted in seven serous cystadenomas, two solid pseudopapillary neoplasms and one mucinous cystadenoma, and eight patients (22%) had focal, mass-forming pancreatitis that consisted in five chronic pancreatitis and three auto-immune pancreatitis. The gender and age distribution in each group of patients are described in Table 1 .
The diagnosis of pancreatic cancer was histopathologically confirmed after surgical resection (n = 9), endoscopic ultrasound-guided biopsy (n = 3) or percutaneous computed-tomography guided biopsy (n = 6). The diagnosis of mass-forming chronic pancreatitis was histopathologically confirmed after surgical resection (n = 2) or endoscopic ultrasound-guided biopsy and a follow-up of at least 10-months (n = 3). The diagnosis of mass-forming auto-immune pancreatitis was made on the basis of histopathological analysis after endoscopic ultrasound-guided biopsy and a favorable response to steroid therapy. The diagnosis of serous and mucinous cystadenoma was histopathologically confirmed after surgical resection. The diagnosis of solid pseudopapillary neoplasm was made after surgical resection; both were considered non-malignant but with uncertain potential for malignancy, with complete encapsulation and without atypia [20, 21] . For all patients, the time interval between DWI and histopathological confirmation was less than 10 days (mean, 3.4 days; range, 1-9 days).
MR examination protocol
All patients underwent MR imaging examination of the abdomen using a 1.5-T system (Magnetom Avanto ® , Siemens Healthcare, Erlangen, Germany, running software Syngo MR B15). High-resolution free-breathing T2-weighted fast spinecho sequence with respiratory triggering using prospective acquisition correction and three-dimensional volumetric interpolated breath-hold gradient-echo (3D VIBE) sequence before and after intravenous administration of a gadoliniumchelate were obtained in all patients in addition to DWI sequence. All imaging examinations were performed with a nine-channel anterior phased-array coil and a nine-channel posterior phased-array coil. Patients were imaged in supine position.
DWI was performed with a fat-suppressed single-shot spin-echo echo-planar diffusion-weighted technique in the axial plane with three gradient factors (b values = 0, 400 and 800 s/mm 2 ) within the same acquisition. The diffusion gradients were applied in three orthogonal directions along the three main axes of the magnet bore (i. e., frequency, phase and slice select directions). The single-shot echo-planar imaging readout was preceded by a diffusionsensitizing block consisting of two 180
• radiofrequency pulses. Parallel imaging with generalized autocalibrating partially parallel acquisition (GRAPPA) was used with an acceleration factor (or reduction factor) of 2. Fat suppression consisted of a spectral adiabatic inversionrecovery (SPAIR) technique [22] . DWI was obtained using a respiratory-triggered acquisition and prior to gadoliniumchelate administration in all patients. The other parameters were as follows: repetition time/echo time, 5300 ms/75 ms; echo spacing, 0.69 ms; matrix size, 182 × 192; 6/8 partial Fourier acquisition; section thickness, 6 mm; intersection gap, 1 mm; voxel size, 2.1 × 2.0 × 6.0 mm; field of view 380 mm; number of signal averages, 4; echo-planar imaging factor, 148; receiver bandwidth, 1736 Hz/pixel; 30 axial sections acquired; acquisition time, 257 s. Imaging datasets were reconstructed using a GRAPPA-based algorithm. No specific bowel preparation was used before MR examination and no antispasmodic agents were given to the patients.
Image analysis
MR images were analyzed using a commercially available workstation (MMWP with the Syngo Software, Siemens Healthcare) by two observers (one fourth-year resident in radiology and one radiologist with 21 years of experience in interpreting abdominal MR images) working in consensus, blinded to the histological nature of the focal pancreatic lesions. For each focal pancreatic lesion, largest axial diameter and location were recorded.
The two observers placed regions of interest (ROIs) to encompass as much as possible of each focal pancreatic lesion on the diffusion-weighted images obtained with b = 0 s/mm 2 . However, a 1-mm peripheral margin of focal pancreatic lesion was left outside the ROI to avoid including adjacent pancreatic parenchyma within the ROI. During the same session, circular ROIs with a minimum size of 100 pixels were placed on each of the four pancreatic segments. Special care was given to avoid pancreatic vessels, pancreatic ducts, calcifications and artifacts in ROI placement. The ROIs were then transferred from the b 0 images to the ADC maps by using the ''copy-and-paste'' function of the workstation.
The ADC maps were generated automatically from the source data using the integrated Syngo software and ADC values were calculated with three b values, including the b = 0, 400 and 800 values s/mm 2 using a mono-exponential fitting algorithm [23] . Because the b = 0 value was included for ADC calculation, the resulting ADC was the ADCtotal and we did not separate perfusion and true diffusion effects [16, 23] . ADC and normalized ADC were calculated. Normalized ADC was defined as the ratio of focal pancreatic lesion ADC to apparently normal adjacent pancreas ADC.
The four pancreatic segments were defined as follows: the head was defined as the pancreatic segment located between the superior mesenteric vein and the gastroduodenal artery, that lies to the right of the superior mesenteric artery; the neck (or isthmus) was the thin section between the head and the body of the gland that lies anterior to the confluence of the superior mesenteric vein and splenic vein, which grooves its posterior aspect; the body was defined as the longest portion of the pancreas, extending from the neck and passing to the tail, lying to the left of the superior mesenteric vessels; the tail was defined as the final portion of the left pancreas, that lies anterior to the left kidney adjacent to the splenic hilum [24] .
Statistical analysis
Lesion sizes and results of ADC measurements for each focal pancreatic lesion and pancreatic parenchyma were expressed as medians, first quartiles (q1), third quartiles (q3) and ranges. Lesion sizes, ADC and normalized ADC values were compared between subgroups of focal pancreatic lesions with the Kruskal-Wallis test for overall comparison and the Wilcoxon signed rank test was used when overall comparison was significant. Pairwise comparisons of the ADC values obtained for the different pancreatic segments were made using the Wilcoxon signed rank test.
R software (version 2.8, R Foundation, http://www. r-project.org/) was used for statistical analysis. All statistical tests were two-tailed and statistical significance was considered at P < 0.05.
Results
Largest axial diameters of focal pancreatic lesions as well as lesion location with respect to specific pancreatic segment are reported in Table 1 . No significant differences in lesion size were found between the three groups of focal pancreatic lesions (P = 0.775).
No significant differences in ADC values were found between the four pancreatic segments (Tables 2 & 3) . Similarly, no differences in ADC values of apparently healthy pancreatic parenchyma were found between the three groups of focal pancreatic lesions (Table 4 ).
Significant differences in ADC values were found between malignant tumors (1.150 × 10 −3 mm 2 /s) ( Fig. 1) (Fig. 4) (P = 0.0005) but not between malignant tumors and mass-forming pancreatitis (P = 0.1092) ( Table 5 ). In addition, overlap in ADC values between the three subgroups of focal pancreatic lesions was observed (Fig. 5) .
Using normalized ADC, significant differences were found between malignant tumors (0.933 × 10 −3 mm 2 /s), benign tumors (1.807 × 10 −3 mm 2 /s) and mass-forming pancreatitis (0.839 × 10 −3 mm 2 /s) (P < 0.0001). Table 6 shows normalized ADC of pancreatic lesions according to lesion type. By comparison with ADC, less degrees of overlap in normalized ADC were observed (Fig. 6 ).
Discussion
As stressed recently, one major limitation of DWI is the difficulty to differentiate between pancreatic adenocarcinoma and mass-forming pancreatitis because of overlap in ADC values [17] . Our preliminary results show that normalized ADC helps characterize focal pancreatic lesions and further discriminate between pancreatic cancers and mass-forming pancreatitis. In our study, the use of the conventional ADC was less discriminating because of marked overlap in ADC values between these two entities, and this was consistent with the results of other researchers [23] . The results of our study show that ADC measurements using a normalized ADC is more discriminating than the more common ADC to differentiate between focal pancreatic lesions, and more specifically between malignant pancreatic tumors and massforming pancreatitis. Recent studies have evaluated the capabilities of ADC measurement in discriminating between malignant and benign pancreatic conditions and other have determined to what extent ADC measurement helps grade the severity of chronic pancreatitis [10] [11] [12] . In this regard, some authors found that malignant pancreatic tumors have ADC values significantly lower than that of normal pancreatic parenchyma as observed in our study [11, 16] . Q1: lower quartile; Q3: upper quartile. Apparent diffusion coefficient (ADC) indicates apparent diffusion coefficient. Significant differences in ADC values were found between the three groups of patients (P = 0.0014; Kruskal-Wallis test) because of significant difference between malignant and benign tumors (P = 0.004) and between benign tumors and mass-forming pancreatitis (P = 0.0005). Conversely, no differences were found between malignant tumors and mass-forming pancreatitis (P = 0.1092). Q1: lower quartile; Q3: upper quartile. Apparent diffusion coefficient (ADC) indicates apparent diffusion coefficient. Significant differences in ADC values were found between the three groups of patients (P < 0.0001; Kruskal-Wallis test) with a significant difference between malignant and benign tumors (P < 0.0001), between benign tumors and mass-forming pancreatitis (P < 0.0001) and between malignant tumors and mass-forming pancreatitis (P = 0.0144).
Several groups have investigated the potential role of ADC measurement in discriminating between malignant pancreatic tumors and mass-forming pancreatitis [14] [15] [16] 25, 26] . As reported recently by Vermoolen et al. [27] , inconsistencies were found between studies. Whereas Lee et al. [16] and Takeuchi et al. [25] found lower ADC values in benign pancreatic lesions by comparison with those observed in malignant ones, reversed results were reported by Fattahi et al. [14] , Kartalis et al. [15] and Yamashita et al. [26] . Our results mirror those reported by Lee were significantly lower than that of pancreatic parenchyma of control patients without pancreatic disease [16] . Conversely, the same group observed lower ADC values for mass-forming pancreatitis by comparison with pancreatic cancer, although we did not find such difference in our study using ADC. By contrast, we found such differences between these two conditions using normalized ADC only. Previous studies have reported ADC values of the normal pancreas using parallel imaging at 1.5-T and marked variations were found among studies. Using a free-breathing technique without respiratory triggering and that included b 0 for ADC calculation (0 s/mm 2 ≤ b ≤ 800 s/mm 2 ), Rosenkrantz et al. found mean ADC values of 1.26 × 10 −3 mm 2 /s at 1.5-T for normal pancreatic parenchyma, which are close to the overall ADC values we found, irrespective to the type of focal pancreatic lesion being present [22] . Conversely, using a breath-hold technique at 1.5-T with two b values of 50-and 500-s/mm 2 , Wiggermann et al. found a very low ADC of 0.17 × 10 −3 mm 2 /s [10] . Using a free-breathing technique at 1.5-T and three b values of 0-, 500-and 1000-s/mm 2 , another group of researchers found ADC values ranging from 1.59 × 10 −3 mm 2 /s to 1.68 × 10 -3 mm 2 /s for normal pancreatic parenchyma, with no significant differences between the three pancreatic segments (head, body and tail) [28] . It has been assumed that variations in ADC values may be the results of differences in patient population, imaging sequences, selection of specific b values for ADC calculation, or other technical acquisition parameters such as slice thickness [10, 28, 29] . In addition, calculation of ADC values may be influenced by the inclusion of low b values as explained by the intravoxel incoherent motion (IVIM) theory [30, 31] . In our study, for a given ROI, we obtained a total ADC value that consisted in the added results of diffusion and microperfusion effects. The effect of microperfusion on the resulting total ADC is more prominent using low b values [32] .
In our study, we found that the apparently normal parenchyma showed homogeneous distribution of ADC values among the four pancreatic segments, in accordance with the results of other studies [33] . However, we are aware of a study in which the pancreatic tail had lower ADC value by comparison with the head and the body [34] .
Pancreatic adenocarcinoma is usually associated with low ADC values by comparison with those of healthy pancreatic parenchyma because of the presence of fibrosis and increased cellularity, which are associated with restricted water diffusion [35] . However, necrosis, which is a frequent component of pancreatic adenocarcinoma, is responsible for increased ADC values due to increased random motion of water molecules [35] . Consequently, variations in ADC found among individual studies may be due to marked differences in the relative proportions of fibrosis and necrosis and degree of cellularity within the tumors.
Differentiation between mass-forming pancreatitis and pancreatic cancer with conventional ADC measurement is not so straightforward because of inconsistencies and conflicting results between published studies [17] . Some studies reported greater ADC values for mass-forming pancreatitis than for pancreatic cancers [14, 15] , others reported greater ADC values for pancreatic cancers than for mass-forming pancreatitis [16, 25] whereas we and others did not find any significant differences in ADC values between these two conditions [10, 23] . One reason may be that mass-forming pancreatitis may contain variable proportions of fibrosis and inflammation, which may explain variations among studies and overlap in ADC values between mass-forming pancreatitis and pancreatic cancers [36] .
In our preliminary study, we have defined a normalized ADC using the pancreatic parenchyma as reference. ADC normalization has been defined already in the abdomen using the spleen as a reference organ [18] . We preferred using the adjacent pancreatic parenchyma for normalization because measurements were made easier with ROIs used for calculation placed on the same level of slice and because we assumed that the adjacent parenchyma was subjected to the same field heterogeneity and susceptibility effects than the lesion. However, we agree upon the fact that the apparently healthy pancreatic parenchyma used for normalization may be involved at some degrees by the underlying pancreatic disease. In this regard, Momtahen et al. found lower ADC values for the pancreatic parenchyma of disease-free patients than for that of patients with mass-forming pancreatitis [36] .
Our study has several limitations. First, our results were obtained from a limited cohort study, reflecting our preliminary experience. Second, we used a respiratory-triggered technique for DWI so that our results may apply only for this specific acquisition technique [37, 38] . A third limitation is that we only calculated ADC total. We agree that further studies should be done to address this concern and that the IVIM model should be applied to investigate the discriminating capabilities of the perfusion fraction (f) and the perfusion free diffusion parameter (D) [39, 40] . Similarly, further studies should be done to investigate at what extent the number of b values may modify normalized ADC [1, 5] .
In conclusion, our preliminary results suggest that normalizing ADC of focal pancreatic lesions with ADC of apparently normal adjacent pancreatic parenchyma allows to discriminate between different types of focal pancreatic lesions. Further studies, however, are needed to fully evaluate to what extent normalized ADC can be used to fully characterize focal pancreatic lesions. In addition, our preliminary results obtained in a relatively small population should warrant further confirmation by larger prospective trials.
TAKE-HOME MESSAGES
• significant differences in normalized ADC values exist between focal pancreatic lesion subtypes; • normalized ADC improves characterization of focal pancreatic lesions; • normalized ADC should be preferred to conventional ADC.
